{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"97.26","value":"56.6"},{"groupId":"OG001","spread":"45","value":"22.5"},{"groupId":"OG002","spread":"87.21","value":"63.2"},{"groupId":"OG003","spread":"2438.34","value":"591.4"},{"groupId":"OG004","spread":"70.04","value":"31"},{"comment":"there was only 1 patient in the group, the standard deviation using the common Bessel correction cannot be derived.","groupId":"OG005","spread":"NA","value":"66.7"},{"groupId":"OG006","spread":"125.59","value":"150.0"},{"groupId":"OG007","spread":"193.25","value":"196.3"},{"groupId":"OG008","spread":"4250.04","value":"1998.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"},{"groupId":"OG003","value":"21"},{"groupId":"OG004","value":"8"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"4"},{"groupId":"OG007","value":"16"},{"groupId":"OG008","value":"5"}],"units":"Participants"}],"description":"All blood samples were drawn immediately prior to each administration of LBH589 dose and at the end of treatment (≤ 7 days post last dose (preferably ≥ 4 days \\[96 hours\\]))","dispersionType":"Standard Deviation","groups":[{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG000","title":"Arm 1, Group X (20 mg)"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG001","title":"Arm 1, Group x (30 mg)"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG002","title":"Arm 1, Group X (40 mg)"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG003","title":"Arm 1, Group X (60 mg)"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG004","title":"Arm 1, Group X (80 mg)"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG005","title":"Arm 1, Group Y (20 mg)"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG006","title":"Arm 1, Group Y (30 mg)"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG007","title":"Arm 1, Group Y (40mg)"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF), every week.","id":"OG008","title":"Arm 1, Group Y (60 mg)"}],"paramType":"MEAN","populationDescription":"Full Analysis Set (with available samples for analysis)","reportingStatus":"POSTED","timeFrame":"Post dose to pre-dose (up to 3.5 years)","title":"Highest Percent Change in Fetal Hemoglobin From Baseline in Arm 1 (MWF Every Week)","type":"SECONDARY","unitOfMeasure":"Percent Change"}